The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Glucocorticoid Injection Market Research Report 2025

Global Glucocorticoid Injection Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1985037

No of Pages : 89

Synopsis
Corticosteroid injections are a commonly used form of medication used to provide fast, effective treatment results. Glucocorticoids are a class of drugs with anti-inflammatory, immunosuppressive and anti-allergic effects and are widely used in the treatment of a variety of diseases. Glucocorticoids can be divided into three categories: short-acting, medium-acting and long-acting according to their duration of action.
The global Glucocorticoid Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Glucocorticoid Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glucocorticoid Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glucocorticoid Injection include Pfizer, SiNi Pharma, Wellona Pharma, AdvaCare Pharma, Eurocrit Labs, Pyxus Pharmaceutical, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Caspian Tamin Pharmaceutical Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucocorticoid Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucocorticoid Injection.
The Glucocorticoid Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Glucocorticoid Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucocorticoid Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
SiNi Pharma
Wellona Pharma
AdvaCare Pharma
Eurocrit Labs
Pyxus Pharmaceutical
Zydus Cadila
Weefsel Pharma
Taj Pharmaceuticals Limited
Caspian Tamin Pharmaceutical Company
Cipla Ltd
Nexphex Global Pharma Private Limited
Criticine Care
Nephron Pharmaceuticals
Segment by Type
Beclomethasone Injection
Betamethasone Injection
Budesonide Injection
Cortisone Injection
Dexamethasone Injection
Hydrocortisone Injection
Methylprednisolone Injection
Prednisolone Injection
Segment by Application
Rheumatoid Arthritis
Allergic Diseases
Bronchial Asthma
Autoimmune Disease
Skin Diseases
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucocorticoid Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucocorticoid Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Index
1 Glucocorticoid Injection Market Overview
1.1 Product Definition
1.2 Glucocorticoid Injection by Type
1.2.1 Global Glucocorticoid Injection Market Value Comparison by Type (2024-2030)
1.2.2 Beclomethasone Injection
1.2.3 Betamethasone Injection
1.2.4 Budesonide Injection
1.2.5 Cortisone Injection
1.2.6 Dexamethasone Injection
1.2.7 Hydrocortisone Injection
1.2.8 Methylprednisolone Injection
1.2.9 Prednisolone Injection
1.3 Glucocorticoid Injection by Application
1.3.1 Global Glucocorticoid Injection Market Value by Application (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Allergic Diseases
1.3.4 Bronchial Asthma
1.3.5 Autoimmune Disease
1.3.6 Skin Diseases
1.3.7 Others
1.4 Global Glucocorticoid Injection Market Size Estimates and Forecasts
1.4.1 Global Glucocorticoid Injection Revenue 2019-2030
1.4.2 Global Glucocorticoid Injection Sales 2019-2030
1.4.3 Global Glucocorticoid Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucocorticoid Injection Market Competition by Manufacturers
2.1 Global Glucocorticoid Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucocorticoid Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucocorticoid Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Glucocorticoid Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucocorticoid Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucocorticoid Injection, Product Type & Application
2.7 Global Key Manufacturers of Glucocorticoid Injection, Date of Enter into This Industry
2.8 Global Glucocorticoid Injection Market Competitive Situation and Trends
2.8.1 Global Glucocorticoid Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glucocorticoid Injection Players Market Share by Revenue
2.8.3 Global Glucocorticoid Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucocorticoid Injection Market Scenario by Region
3.1 Global Glucocorticoid Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucocorticoid Injection Sales by Region: 2019-2030
3.2.1 Global Glucocorticoid Injection Sales by Region: 2019-2024
3.2.2 Global Glucocorticoid Injection Sales by Region: 2025-2030
3.3 Global Glucocorticoid Injection Revenue by Region: 2019-2030
3.3.1 Global Glucocorticoid Injection Revenue by Region: 2019-2024
3.3.2 Global Glucocorticoid Injection Revenue by Region: 2025-2030
3.4 North America Glucocorticoid Injection Market Facts & Figures by Country
3.4.1 North America Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucocorticoid Injection Sales by Country (2019-2030)
3.4.3 North America Glucocorticoid Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucocorticoid Injection Market Facts & Figures by Country
3.5.1 Europe Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucocorticoid Injection Sales by Country (2019-2030)
3.5.3 Europe Glucocorticoid Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucocorticoid Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Glucocorticoid Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucocorticoid Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Glucocorticoid Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glucocorticoid Injection Market Facts & Figures by Country
3.7.1 Latin America Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucocorticoid Injection Sales by Country (2019-2030)
3.7.3 Latin America Glucocorticoid Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Glucocorticoid Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucocorticoid Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucocorticoid Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucocorticoid Injection Sales by Type (2019-2030)
4.1.1 Global Glucocorticoid Injection Sales by Type (2019-2024)
4.1.2 Global Glucocorticoid Injection Sales by Type (2025-2030)
4.1.3 Global Glucocorticoid Injection Sales Market Share by Type (2019-2030)
4.2 Global Glucocorticoid Injection Revenue by Type (2019-2030)
4.2.1 Global Glucocorticoid Injection Revenue by Type (2019-2024)
4.2.2 Global Glucocorticoid Injection Revenue by Type (2025-2030)
4.2.3 Global Glucocorticoid Injection Revenue Market Share by Type (2019-2030)
4.3 Global Glucocorticoid Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucocorticoid Injection Sales by Application (2019-2030)
5.1.1 Global Glucocorticoid Injection Sales by Application (2019-2024)
5.1.2 Global Glucocorticoid Injection Sales by Application (2025-2030)
5.1.3 Global Glucocorticoid Injection Sales Market Share by Application (2019-2030)
5.2 Global Glucocorticoid Injection Revenue by Application (2019-2030)
5.2.1 Global Glucocorticoid Injection Revenue by Application (2019-2024)
5.2.2 Global Glucocorticoid Injection Revenue by Application (2025-2030)
5.2.3 Global Glucocorticoid Injection Revenue Market Share by Application (2019-2030)
5.3 Global Glucocorticoid Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Glucocorticoid Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 SiNi Pharma
6.2.1 SiNi Pharma Company Information
6.2.2 SiNi Pharma Description and Business Overview
6.2.3 SiNi Pharma Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SiNi Pharma Glucocorticoid Injection Product Portfolio
6.2.5 SiNi Pharma Recent Developments/Updates
6.3 Wellona Pharma
6.3.1 Wellona Pharma Company Information
6.3.2 Wellona Pharma Description and Business Overview
6.3.3 Wellona Pharma Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Wellona Pharma Glucocorticoid Injection Product Portfolio
6.3.5 Wellona Pharma Recent Developments/Updates
6.4 AdvaCare Pharma
6.4.1 AdvaCare Pharma Company Information
6.4.2 AdvaCare Pharma Description and Business Overview
6.4.3 AdvaCare Pharma Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AdvaCare Pharma Glucocorticoid Injection Product Portfolio
6.4.5 AdvaCare Pharma Recent Developments/Updates
6.5 Eurocrit Labs
6.5.1 Eurocrit Labs Company Information
6.5.2 Eurocrit Labs Description and Business Overview
6.5.3 Eurocrit Labs Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eurocrit Labs Glucocorticoid Injection Product Portfolio
6.5.5 Eurocrit Labs Recent Developments/Updates
6.6 Pyxus Pharmaceutical
6.6.1 Pyxus Pharmaceutical Company Information
6.6.2 Pyxus Pharmaceutical Description and Business Overview
6.6.3 Pyxus Pharmaceutical Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pyxus Pharmaceutical Glucocorticoid Injection Product Portfolio
6.6.5 Pyxus Pharmaceutical Recent Developments/Updates
6.7 Zydus Cadila
6.7.1 Zydus Cadila Company Information
6.7.2 Zydus Cadila Description and Business Overview
6.7.3 Zydus Cadila Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Zydus Cadila Glucocorticoid Injection Product Portfolio
6.7.5 Zydus Cadila Recent Developments/Updates
6.8 Weefsel Pharma
6.8.1 Weefsel Pharma Company Information
6.8.2 Weefsel Pharma Description and Business Overview
6.8.3 Weefsel Pharma Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Weefsel Pharma Glucocorticoid Injection Product Portfolio
6.8.5 Weefsel Pharma Recent Developments/Updates
6.9 Taj Pharmaceuticals Limited
6.9.1 Taj Pharmaceuticals Limited Company Information
6.9.2 Taj Pharmaceuticals Limited Description and Business Overview
6.9.3 Taj Pharmaceuticals Limited Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taj Pharmaceuticals Limited Glucocorticoid Injection Product Portfolio
6.9.5 Taj Pharmaceuticals Limited Recent Developments/Updates
6.10 Caspian Tamin Pharmaceutical Company
6.10.1 Caspian Tamin Pharmaceutical Company Company Information
6.10.2 Caspian Tamin Pharmaceutical Company Description and Business Overview
6.10.3 Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Product Portfolio
6.10.5 Caspian Tamin Pharmaceutical Company Recent Developments/Updates
6.11 Cipla Ltd
6.11.1 Cipla Ltd Company Information
6.11.2 Cipla Ltd Description and Business Overview
6.11.3 Cipla Ltd Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cipla Ltd Glucocorticoid Injection Product Portfolio
6.11.5 Cipla Ltd Recent Developments/Updates
6.12 Nexphex Global Pharma Private Limited
6.12.1 Nexphex Global Pharma Private Limited Company Information
6.12.2 Nexphex Global Pharma Private Limited Description and Business Overview
6.12.3 Nexphex Global Pharma Private Limited Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nexphex Global Pharma Private Limited Glucocorticoid Injection Product Portfolio
6.12.5 Nexphex Global Pharma Private Limited Recent Developments/Updates
6.13 Criticine Care
6.13.1 Criticine Care Company Information
6.13.2 Criticine Care Description and Business Overview
6.13.3 Criticine Care Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Criticine Care Glucocorticoid Injection Product Portfolio
6.13.5 Criticine Care Recent Developments/Updates
6.14 Nephron Pharmaceuticals
6.14.1 Nephron Pharmaceuticals Company Information
6.14.2 Nephron Pharmaceuticals Description and Business Overview
6.14.3 Nephron Pharmaceuticals Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nephron Pharmaceuticals Glucocorticoid Injection Product Portfolio
6.14.5 Nephron Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucocorticoid Injection Industry Chain Analysis
7.2 Glucocorticoid Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucocorticoid Injection Production Mode & Process
7.4 Glucocorticoid Injection Sales and Marketing
7.4.1 Glucocorticoid Injection Sales Channels
7.4.2 Glucocorticoid Injection Distributors
7.5 Glucocorticoid Injection Customers
8 Glucocorticoid Injection Market Dynamics
8.1 Glucocorticoid Injection Industry Trends
8.2 Glucocorticoid Injection Market Drivers
8.3 Glucocorticoid Injection Market Challenges
8.4 Glucocorticoid Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Glucocorticoid Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Glucocorticoid Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Glucocorticoid Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Glucocorticoid Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Glucocorticoid Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Glucocorticoid Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Glucocorticoid Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Glucocorticoid Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Glucocorticoid Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glucocorticoid Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glucocorticoid Injection, Product Type & Application
Table 12. Global Key Manufacturers of Glucocorticoid Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glucocorticoid Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucocorticoid Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glucocorticoid Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Glucocorticoid Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Glucocorticoid Injection Sales Market Share by Region (2019-2024)
Table 19. Global Glucocorticoid Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Glucocorticoid Injection Sales Market Share by Region (2025-2030)
Table 21. Global Glucocorticoid Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Glucocorticoid Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Glucocorticoid Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Glucocorticoid Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Glucocorticoid Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Glucocorticoid Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Glucocorticoid Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Glucocorticoid Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Glucocorticoid Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Glucocorticoid Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Glucocorticoid Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Glucocorticoid Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Glucocorticoid Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Glucocorticoid Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Glucocorticoid Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Glucocorticoid Injection Sales Market Share by Type (2019-2024)
Table 53. Global Glucocorticoid Injection Sales Market Share by Type (2025-2030)
Table 54. Global Glucocorticoid Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Glucocorticoid Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Glucocorticoid Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Glucocorticoid Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Glucocorticoid Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Glucocorticoid Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Glucocorticoid Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Glucocorticoid Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Glucocorticoid Injection Sales Market Share by Application (2019-2024)
Table 63. Global Glucocorticoid Injection Sales Market Share by Application (2025-2030)
Table 64. Global Glucocorticoid Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Glucocorticoid Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Glucocorticoid Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Glucocorticoid Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Glucocorticoid Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Glucocorticoid Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Glucocorticoid Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. SiNi Pharma Company Information
Table 76. SiNi Pharma Description and Business Overview
Table 77. SiNi Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. SiNi Pharma Glucocorticoid Injection Product
Table 79. SiNi Pharma Recent Developments/Updates
Table 80. Wellona Pharma Company Information
Table 81. Wellona Pharma Description and Business Overview
Table 82. Wellona Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Wellona Pharma Glucocorticoid Injection Product
Table 84. Wellona Pharma Recent Developments/Updates
Table 85. AdvaCare Pharma Company Information
Table 86. AdvaCare Pharma Description and Business Overview
Table 87. AdvaCare Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AdvaCare Pharma Glucocorticoid Injection Product
Table 89. AdvaCare Pharma Recent Developments/Updates
Table 90. Eurocrit Labs Company Information
Table 91. Eurocrit Labs Description and Business Overview
Table 92. Eurocrit Labs Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Eurocrit Labs Glucocorticoid Injection Product
Table 94. Eurocrit Labs Recent Developments/Updates
Table 95. Pyxus Pharmaceutical Company Information
Table 96. Pyxus Pharmaceutical Description and Business Overview
Table 97. Pyxus Pharmaceutical Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pyxus Pharmaceutical Glucocorticoid Injection Product
Table 99. Pyxus Pharmaceutical Recent Developments/Updates
Table 100. Zydus Cadila Company Information
Table 101. Zydus Cadila Description and Business Overview
Table 102. Zydus Cadila Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Zydus Cadila Glucocorticoid Injection Product
Table 104. Zydus Cadila Recent Developments/Updates
Table 105. Weefsel Pharma Company Information
Table 106. Weefsel Pharma Description and Business Overview
Table 107. Weefsel Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Weefsel Pharma Glucocorticoid Injection Product
Table 109. Weefsel Pharma Recent Developments/Updates
Table 110. Taj Pharmaceuticals Limited Company Information
Table 111. Taj Pharmaceuticals Limited Description and Business Overview
Table 112. Taj Pharmaceuticals Limited Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Taj Pharmaceuticals Limited Glucocorticoid Injection Product
Table 114. Taj Pharmaceuticals Limited Recent Developments/Updates
Table 115. Caspian Tamin Pharmaceutical Company Company Information
Table 116. Caspian Tamin Pharmaceutical Company Description and Business Overview
Table 117. Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Product
Table 119. Caspian Tamin Pharmaceutical Company Recent Developments/Updates
Table 120. Cipla Ltd Company Information
Table 121. Cipla Ltd Description and Business Overview
Table 122. Cipla Ltd Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Cipla Ltd Glucocorticoid Injection Product
Table 124. Cipla Ltd Recent Developments/Updates
Table 125. Nexphex Global Pharma Private Limited Company Information
Table 126. Nexphex Global Pharma Private Limited Description and Business Overview
Table 127. Nexphex Global Pharma Private Limited Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Nexphex Global Pharma Private Limited Glucocorticoid Injection Product
Table 129. Nexphex Global Pharma Private Limited Recent Developments/Updates
Table 130. Criticine Care Company Information
Table 131. Criticine Care Description and Business Overview
Table 132. Criticine Care Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Criticine Care Glucocorticoid Injection Product
Table 134. Criticine Care Recent Developments/Updates
Table 135. Nephron Pharmaceuticals Company Information
Table 136. Nephron Pharmaceuticals Description and Business Overview
Table 137. Nephron Pharmaceuticals Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Nephron Pharmaceuticals Glucocorticoid Injection Product
Table 139. Nephron Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Glucocorticoid Injection Distributors List
Table 143. Glucocorticoid Injection Customers List
Table 144. Glucocorticoid Injection Market Trends
Table 145. Glucocorticoid Injection Market Drivers
Table 146. Glucocorticoid Injection Market Challenges
Table 147. Glucocorticoid Injection Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report


List of Figures
Figure 1. Product Picture of Glucocorticoid Injection
Figure 2. Global Glucocorticoid Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Glucocorticoid Injection Market Share by Type: 2023 & 2030
Figure 4. Beclomethasone Injection Product Picture
Figure 5. Betamethasone Injection Product Picture
Figure 6. Budesonide Injection Product Picture
Figure 7. Cortisone Injection Product Picture
Figure 8. Dexamethasone Injection Product Picture
Figure 9. Hydrocortisone Injection Product Picture
Figure 10. Methylprednisolone Injection Product Picture
Figure 11. Prednisolone Injection Product Picture
Figure 12. Global Glucocorticoid Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 13. Global Glucocorticoid Injection Market Share by Application: 2023 & 2030
Figure 14. Rheumatoid Arthritis
Figure 15. Allergic Diseases
Figure 16. Bronchial Asthma
Figure 17. Autoimmune Disease
Figure 18. Skin Diseases
Figure 19. Others
Figure 20. Global Glucocorticoid Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Glucocorticoid Injection Market Size (2019-2030) & (US$ Million)
Figure 22. Global Glucocorticoid Injection Sales (2019-2030) & (K Units)
Figure 23. Global Glucocorticoid Injection Average Price (US$/Unit) & (2019-2030)
Figure 24. Glucocorticoid Injection Report Years Considered
Figure 25. Glucocorticoid Injection Sales Share by Manufacturers in 2023
Figure 26. Global Glucocorticoid Injection Revenue Share by Manufacturers in 2023
Figure 27. Global 5 and 10 Largest Glucocorticoid Injection Players: Market Share by Revenue in Glucocorticoid Injection in 2023
Figure 28. Glucocorticoid Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 29. Global Glucocorticoid Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 30. North America Glucocorticoid Injection Sales Market Share by Country (2019-2030)
Figure 31. North America Glucocorticoid Injection Revenue Market Share by Country (2019-2030)
Figure 32. United States Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Canada Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Europe Glucocorticoid Injection Sales Market Share by Country (2019-2030)
Figure 35. Europe Glucocorticoid Injection Revenue Market Share by Country (2019-2030)
Figure 36. Germany Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. France Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. U.K. Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Italy Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Russia Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Asia Pacific Glucocorticoid Injection Sales Market Share by Region (2019-2030)
Figure 42. Asia Pacific Glucocorticoid Injection Revenue Market Share by Region (2019-2030)
Figure 43. China Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Japan Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. South Korea Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. India Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Australia Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. China Taiwan Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Glucocorticoid Injection Sales Market Share by Country (2019-2030)
Figure 51. Mexico Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Colombia Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Middle East and Africa Glucocorticoid Injection Sales Market Share by Country (2019-2030)
Figure 56. Middle East and Africa Glucocorticoid Injection Revenue Market Share by Country (2019-2030)
Figure 57. Turkey Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. UAE Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Global Sales Market Share of Glucocorticoid Injection by Type (2019-2030)
Figure 61. Global Revenue Market Share of Glucocorticoid Injection by Type (2019-2030)
Figure 62. Global Glucocorticoid Injection Price (US$/Unit) by Type (2019-2030)
Figure 63. Global Sales Market Share of Glucocorticoid Injection by Application (2019-2030)
Figure 64. Global Revenue Market Share of Glucocorticoid Injection by Application (2019-2030)
Figure 65. Global Glucocorticoid Injection Price (US$/Unit) by Application (2019-2030)
Figure 66. Glucocorticoid Injection Value Chain
Figure 67. Glucocorticoid Injection Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’